Literature DB >> 27797899

Use of Oral Anticoagulation for Patients with ESRD on Hemodialysis with Atrial Fibrillation: Verdict 1.

Nisha Bansal1.   

Abstract

Entities:  

Keywords:  Anticoagulants; Atrial Fibrillation; Blood Coagulation; Chronic; Disease Management; ESRD; Humans; Kidney Failure; cardiovascular disease; dialysis

Mesh：

Substances：

Year:  2016        PMID： 27797899      PMCID： PMC5108201          DOI： 10.2215/CJN.08610816

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  20 in total

1.  Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation.

Authors:  Wolfgang C Winkelmayer; Jun Liu; Soko Setoguchi; Niteesh K Choudhry
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-29       Impact factor: 8.237

2.  Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis.

Authors:  Mitesh Shah; Meytal Avgil Tsadok; Cynthia A Jackevicius; Vidal Essebag; Mark J Eisenberg; Elham Rahme; Karin H Humphries; Jack V Tu; Hassan Behlouli; Helen Guo; Louise Pilote
Journal:  Circulation       Date:  2014-01-22       Impact factor: 29.690

3.  Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease.

Authors:  John W Eikelboom; Stuart J Connolly; Peggy Gao; Ernesto Paolasso; Raffaele De Caterina; Steen Husted; Martin O'Donnell; Salim Yusuf; Robert G Hart
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-08       Impact factor: 2.136

4.  Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Pro.

Authors:  Peter A McCullough; Timothy Ball; Katy Mathews Cox; Manish D Assar
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-25       Impact factor: 8.237

Review 5.  Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Con.

Authors:  Vaibhav Keskar; Manish M Sood
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-25       Impact factor: 8.237

6.  Dabigatran and rivaroxaban use in atrial fibrillation patients on hemodialysis.

Authors:  Kevin E Chan; Elazer R Edelman; Julia B Wenger; Ravi I Thadhani; Franklin W Maddux
Journal:  Circulation       Date:  2015-01-16       Impact factor: 29.690

7.  Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation.

Authors:  Jenny I Shen; Maria E Montez-Rath; Colin R Lenihan; Mintu P Turakhia; Tara I Chang; Wolfgang C Winkelmayer
Journal:  Am J Kidney Dis       Date:  2015-07-07       Impact factor: 8.860

8.  Atrial fibrillation and risk of stroke in dialysis patients.

Authors:  James B Wetmore; Edward F Ellerbeck; Jonathan D Mahnken; Milind Phadnis; Sally K Rigler; Purna Mukhopadhyay; John A Spertus; Xinhua Zhou; Qingjiang Hou; Theresa I Shireman
Journal:  Ann Epidemiol       Date:  2013-01-16       Impact factor: 3.797

9.  Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end-stage renal disease on hemodialysis.

Authors:  Xiaoli Wang; Giridhar Tirucherai; Thomas C Marbury; Jessie Wang; Ming Chang; Donglu Zhang; Yan Song; Janice Pursley; Rebecca A Boyd; Charles Frost
Journal:  J Clin Pharmacol       Date:  2015-12-22       Impact factor: 3.126

10.  The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study.

Authors:  Min Jun; Matthew T James; Braden J Manns; Robert R Quinn; Pietro Ravani; Marcello Tonelli; Vlado Perkovic; Wolfgang C Winkelmayer; Zhihai Ma; Brenda R Hemmelgarn
Journal:  BMJ       Date:  2015-02-03
View more
  4 in total

1.  Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease.

Authors:  Nishank Jain; Robert F Reilly
Journal:  Clin J Am Soc Nephrol       Date:  2018-05-25       Impact factor: 8.237

2.  Relation of Race, Apparent Disability, and Stroke Risk With Warfarin Prescribing for Atrial Fibrillation in Patients Receiving Maintenance Hemodialysis.

Authors:  James B Wetmore; Yi Peng; David T Gilbertson; Jiannong Liu
Journal:  Am J Cardiol       Date:  2018-11-24       Impact factor: 2.778

Review 3.  Anticoagulation in CKD and ESRD.

Authors:  Kelvin Cheuk-Wai Leung; Jennifer Marie MacRae
Journal:  J Nephrol       Date:  2019-01-28       Impact factor: 3.902

4.  Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study.

Authors:  Holger Reinecke; Sabine Jürgensmeyer; Christiane Engelbertz; Joachim Gerss; Paulus Kirchhof; Günter Breithardt; Rupert Bauersachs; Christoph Wanner
Journal:  BMJ Open       Date:  2018-09-10       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.